Matches in Wikidata for { <http://www.wikidata.org/entity/Q100431670> ?p ?o ?g. }
Showing items 1 to 38 of
38
with 100 items per page.
- Q100431670 description "artículu científicu espublizáu n'ochobre de 2020" @default.
- Q100431670 description "scientific article published on 02 October 2020" @default.
- Q100431670 description "wetenschappelijk artikel" @default.
- Q100431670 description "наукова стаття, опублікована 2 жовтня 2020" @default.
- Q100431670 name "Differences in uptake and intracellular fate between Bevacizumab and Aflibercept after repetitive long-term treatment in the RPE" @default.
- Q100431670 name "Differences in uptake and intracellular fate between Bevacizumab and Aflibercept after repetitive long-term treatment in the RPE" @default.
- Q100431670 name "Differences in uptake and intracellular fate between Bevacizumab and Aflibercept after repetitive long-term treatment in the RPE" @default.
- Q100431670 type Item @default.
- Q100431670 label "Differences in uptake and intracellular fate between Bevacizumab and Aflibercept after repetitive long-term treatment in the RPE" @default.
- Q100431670 label "Differences in uptake and intracellular fate between Bevacizumab and Aflibercept after repetitive long-term treatment in the RPE" @default.
- Q100431670 label "Differences in uptake and intracellular fate between Bevacizumab and Aflibercept after repetitive long-term treatment in the RPE" @default.
- Q100431670 prefLabel "Differences in uptake and intracellular fate between Bevacizumab and Aflibercept after repetitive long-term treatment in the RPE" @default.
- Q100431670 prefLabel "Differences in uptake and intracellular fate between Bevacizumab and Aflibercept after repetitive long-term treatment in the RPE" @default.
- Q100431670 prefLabel "Differences in uptake and intracellular fate between Bevacizumab and Aflibercept after repetitive long-term treatment in the RPE" @default.
- Q100431670 P1433 Q100431670-B7DC62C6-A324-4125-B0B6-117F6140266D @default.
- Q100431670 P1476 Q100431670-99CF2582-41A8-414C-B68B-03BE37E50751 @default.
- Q100431670 P2093 Q100431670-42D55DB0-C6D5-4B65-9E18-9E1FA7B084F9 @default.
- Q100431670 P2093 Q100431670-4C8BDECB-5401-4A42-A6A6-CDB3D9A5FC18 @default.
- Q100431670 P2093 Q100431670-A3DA5F9C-D622-43F6-AE4D-A07D48719212 @default.
- Q100431670 P31 Q100431670-A74577A9-4808-4646-8AA5-184ED993A311 @default.
- Q100431670 P356 Q100431670-1C69D290-2A0B-4131-A3B7-ECB087D1C7E1 @default.
- Q100431670 P577 Q100431670-15DBF34B-F07B-4F67-B826-19E486567E82 @default.
- Q100431670 P698 Q100431670-DEAAD287-01F9-453D-84B2-F3AAC98CAD81 @default.
- Q100431670 P921 Q100431670-477BBA9E-F225-4890-B183-0091CDD94F6B @default.
- Q100431670 P921 Q100431670-D960A52B-1912-411B-AC42-8EDBF75F048B @default.
- Q100431670 P356 000511960 @default.
- Q100431670 P698 33011724 @default.
- Q100431670 P1433 Q15759090 @default.
- Q100431670 P1476 "Differences in uptake and intracellular fate between Bevacizumab and Aflibercept after repetitive long-term treatment in the RPE" @default.
- Q100431670 P2093 "Alexa Klettner" @default.
- Q100431670 P2093 "Johann Roider" @default.
- Q100431670 P2093 "Laura Borchers" @default.
- Q100431670 P31 Q13442814 @default.
- Q100431670 P356 "10.1159/000511960" @default.
- Q100431670 P577 "2020-10-02T00:00:00Z" @default.
- Q100431670 P698 "33011724" @default.
- Q100431670 P921 Q413299 @default.
- Q100431670 P921 Q4689286 @default.